Pediatric Gastroenterology & Hepatology

Pediatric Gastroenterology & Hepatology Lecture Notes

Overview

• Subject: Pediatric Hepatology & Gastroenterology
• Lecturer: Dr. Mohamed Ezz, Professor of Pediatrics, Mansoura University
• Focus: Decoding pediatric hepatology labs, particularly Hepatitis A in children

Chapter 8: Hepatitis A in Children

1. Key Points on Hepatitis A

• Definition: Hepatitis A virus (HAV) is a non-enveloped RNA virus belonging to the Picornaviridae family, primarily transmitted via the fecal-oral route.
• Importance:
  • Infection often asymptomatic or mild in children.
  • Can result in outbreaks, notably in areas with inadequate sanitation.
  • Acute liver failure, though rare, remains a potential outcome.
  • Highly preventable through vaccination and good hygiene practices.

2. Clinical Presentation

• Prodrome Symptoms:
  • Fever
  • Fatigue
  • Nausea
  • Vomiting
  • Anorexia
• Icteric Phase Symptoms:
  • Jaundice
  • Dark urine
  • Pale stool
  • Hepatomegaly
• Course & Duration:
  • Symptoms typically resolve within 4-6 weeks.
• Diagnostic Clues:
  • Sudden-onset jaundice in children.
  • Recent exposure to confirmed cases.
  • Travel to endemic areas or environments with poor sanitation.
  • Outbreaks in a school or family setting.
• Clinical Manifestations:
  • Asymptomatic
  • Symptomatic: Includes cases of acute hepatitis, cholestatic hepatitis, relapsing hepatitis, and very rare fulminant hepatitis.

3. Epidemiology and Complications

• Incubation Period: Average of 4 weeks (range: 2-8 weeks).
• Jaundice by Age Group:
  • Children <6 years: <10% experience jaundice.
  • Children 6-14 years: 40-50% experience jaundice.
  • Adolescents >14 years: 70-80% experience jaundice.
• Complications:
  • Fulminant hepatitis: Sudden severe disease onset, characterized by intense pain.
  • Cholestatic hepatitis: Liver inflammation due to blocked bile excretion.
  • Relapsing hepatitis: Inflammation returning after initial recovery.
  • No chronic sequelae post-infection.
  • No risk for re-infection post-recovery.

4. Key Investigations for Diagnosis

• Investigation Types and Purposes:
  • ALT/AST: Detect liver inflammation, typically elevated (>500 IU/L).
  • Total & Direct Bilirubin: Assess cholestasis, results can vary but typically elevated.
  • PT/INR: Evaluate liver synthetic function, with normal or mildly prolonged results expected.
  • Anti-HAV IgM: Primary diagnostic test for acute infection; will be positive early in the disease and remains detectable for 3-6 months.
  • Anti-HAV IgG: Indicates previous infection or vaccination; becomes positive following recovery or vaccination.
  • Important Note: Anti-HAV IgM is considered the gold standard for confirming acute HAV infection.

5. Differential Diagnosis of Acute Hepatitis in Children

6. Management Principles

• Supportive Care:
  • Ensure hydration and adequate nutrition.
  • Constant monitoring of liver function tests and coagulation profile.
  • Avoid hepatotoxic medications (e.g., paracetamol overdose).
• Indications for Hospitalization:
  • Poor oral intake leading to dehydration.
  • Symptoms include vomiting or altered consciousness, coagulopathy (INR > 1.5).
  • Signs of acute liver failure (e.g., encephalopathy combined with INR ≥ 1.5).

7. Prevention and Public Health Strategies

• Vaccination Recommendations:
  • Two-dose series for children aged 12-23 months, spaced six months apart.
  • Target populations include travelers to endemic areas and children in outbreak settings.
• Post-exposure Prophylaxis:
  • HAV vaccine or immune globulin administration within 14 days of exposure.
• Essential Hygiene Practices:
  • Rigorous hand hygiene and safe food/water consumption are vital for mitigating spread.

8. Prognosis

• Outcomes:
  • Excellent prognosis in over 95% of cases.
  • Liver enzyme levels usually normalize within 2-3 months following infection.
  • No risk of chronic infection or carrier status.
  • Immunity is considered lifelong after infection or vaccination.

9. Summary of Ezz Laws on Hepatitis A Management

• Key Takeaways:
  • Sudden-onset jaundice and clusters of cases warrant suspicion for Hepatitis A.
  • Anti-HAV IgM serves as the definitive diagnostic tool.
  • Core management focuses on supportive care.
  • Prevention hinges on vaccination efforts and maintaining proper hygiene practices.

II. Hepatitis A Markers in Children

1. Overview of Hepatitis A Markers

• Markers Defined: Serological tests that help in diagnosing acute HAV infection and determining immunity from previous infection or vaccination.
• Importance: Vital for evaluating children experiencing jaundice or unexplained liver enzyme abnormalities, and determining HAV susceptibility.

2. Testing Indications

• Symptoms such as jaundice, dark urine, or pale stools.
• Unexplained elevated liver enzymes (ALT/AST) in children.
• Close contact with confirmed HAV cases or being part of outbreaks.
• Rarely, pre-vaccination screening unless prior exposure is suspect.

3. Main Hepatitis A Markers

4. Use of Specific HAV Markers

• Clinical Scenario Guidelines:
  • Suspected Acute HAV Infection: Test HAV IgM for confirmation.
  • Evaluating Immunity: Test HAV IgG.
  • Screening in Outbreaks: Use HAV IgM to identify active cases.
  • Post-Exposure Prophylaxis: Test HAV IgG to assess susceptibility.

5. Interpreting HAV Marker Results

6. HAV Serological Testing Workflow

1. In symptomatic children, test for HAV IgM to confirm acute infection.
2. If HAV IgM is negative, and prior exposure or immunity is a question, proceed to test HAV IgG.
3. In outbreak situations, determine immunity with HAV IgG and offer post-exposure prophylaxis (vaccine or immunoglobulin) to susceptible children.

7. Special Considerations in Children

• In endemic areas, early exposure can lead to positive HAV IgG by adolescence.
• HAV IgM may persist for up to six months post-infection, but clinical monitoring should suffice without re-testing unless symptoms arise.
• HAV infection is typically asymptomatic in children yet can spread, particularly within household settings or schools.

8. Limitations and Challenges

• Occasional false-positive results for HAV IgM may arise due to autoimmune liver disorders or other viral infections.
• HAV IgG testing is less effective for acute diagnosis and should predominantly guide immunity assessments.
• Monitoring recovery via HAV IgM is not valuable; it only confirms presence during acute phases.

III. Case-Based Scenarios on Hepatitis A

Case 1: Classic Acute Hepatitis A

• Patient Profile: 8-year-old male from an area with poor sanitation.
• History: Notable fever for 5 days, anorexia, nausea, and vomiting. Yellowing of the eyes and dark urine noted.
• Examination Findings:
  • Febrile and icteric.
  • Smooth, tender hepatomegaly.
• Key Point: Fever, jaundice, and tender hepatomegaly are classic signs of HAV infection in endemic regions.

Case 2: Cholestatic Variant of HAV

• Patient Profile: 10-year-old female, previously healthy.
• History: Persistent jaundice for 3 weeks with severe itching and pale stools.
• Examination Findings:
  • Deep jaundice with noticeable scratch marks.
  • Hepatomegaly and mild splenomegaly.
• Key Point: Combination of prolonged jaundice, intense pruritus, and pale stools indicates the cholestatic variant of HAV, which often resolves with supportive care.

Case 3: Fulminant Hepatitis A (Severe but Rare)

• Patient Profile: 12-year-old boy without previous health issues.
• History: Fever, vomiting, and jaundice for a week; now presents with lethargy and gum bleeding.
• Examination Findings:
  • Deep jaundice with confusion.
  • Hepatomegaly with tenderness and signs of coagulopathy.
• Investigations:
  • Elevated INR and bilirubin levels, with high ALT/AST.
• Key Point: A presentation of acute hepatitis with encephalopathy and coagulopathy signifies fulminant hepatitis A, necessitating urgent referral to a specialized pediatric liver center.

Case 4: Asymptomatic Contact of HAV

• Patient Profile: 6-year-old boy, sibling of a confirmed case.
• History: No symptom complaints, yet exposed to acute HAV.
• Examination Findings:
  • Normal physical exam, no jaundice.
• Investigations:
  • Elevated liver enzymes with positive anti-HAV IgM.
• Key Point: Asymptomatic liver enzyme elevation indicates silent HAV infection, which is often uncovered during contact screening.

Comparative Table of Cases

• Final Summary: These scenarios illustrate the diverse presentations of Hepatitis A in children, ranging from typical acute illness to prolonged cholestatic forms, severe fulminant presentations, and silent subclinical infections.